You already know about the gastrointestinal ones.
GLP-1 receptor agonists are reshaping care for type 2 diabetes, obesity, chronic kidney disease, and obstructive sleep apnea, ...
The majority of weight loss from GLP-1 medication is from fat loss, and not muscle loss, new evidence suggests.
While GLP-1 medications first gained visibility for diabetes care and later for weight loss, researchers are now evaluating ...
As of April 2026, more than 40 million GLP-1 receptor agonist prescriptions are dispensed annually in the United States alone ...
ColonBroom is taking a more targeted approach. The company has launched an upgraded version of its GLP-1 Premium formula, ...
New research explains the role of genes and other health factors.
A Nature study reports a single-molecule GLP-1–GIP–lanifibranor quintuple agonist that targets incretin receptor-expressing ...
The lead study author and doctors share how these unknown side effects can impact your training and the best ways to adjust ...
GLP-1 medications are popular these days, but the body already naturally produces its own GLP-1. Dr. Mercola, a board-certified family medicine osteopathic physician (DO) and multi-best-selling author ...